BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.34.2.1785239121//EN
X-ORIGINAL-URL:https://elephantsandtea.org/
X-WR-CALNAME:Elephants and Tea
X-WR-CALDESC:The Elephant in the Room is Cancer. Tea is the Relief Conversation Provides.
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-3c8ebb190703254a2cb4ede547c4285c@elephantsandtea.org
DTSTART;TZID=America/New_York:20251022T180000
DTEND;TZID=America/New_York:20251022T190000
DTSTAMP:20251008T151355Z
CREATED:20251008
LAST-MODIFIED:20251008
PRIORITY:5
SEQUENCE:1
TRANSP:OPAQUE
SUMMARY:Cancer Q&A: Understanding the Role and Reality of CAR T-Cell Therapy for Non-Hodgkin Lymphoma
DESCRIPTION:Cancer Q&A: Understanding the Role and Reality of CAR T-Cell Therapy for Non-Hodgkin Lymphoma\nRegister here\nWednesday, October 22, 6:00 p.m. – 7:00 p.m. ET\nIn partnership with Research To Practice®, this special webinar is designed to educate patients about CAR T-cell therapy for non-Hodgkin lymphoma. Participants will learn about what is important in a diagnosis of non-Hodgkin lymphoma, key factors in treatment decision-making and what side effects may be encountered. Led by nationally renowned medical oncologist Dr. Neil Love, this medical webinar is designed to provide accessible information for patients and their friends or family members.\nKey Takeaways\n\nUnderstand how CAR T-cell therapy works and what the treatment experience is like for patients\nLearn about available CAR T-cell therapy options for non-Hodgkin lymphoma\nKnow about potential side effects of CAR T-cell therapy and what is done to prevent and manage them\nContribute to shared decision-making between patients and their healthcare providers\n\nFaculty:\nJeremy S. Abramson, MD, MMSc, Director, Center for Lymphoma, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Boston, Massachusetts\nLoretta J. Nastoupil, MD, Oncologist, Southwest Oncology, CommonSpirit Mercy Hospital, Durango, Colorado\nModerator:\nNeil Love, MD, Research To Practice, Miami, Florida\nSubmit your questions in advance for the faculty to address during the webinar here.\nA Live Webinar for Patients, Developed in Partnership with Research To Practice®.\n
URL:https://www.cancercare.org/community_programs/1016?utm_source=constant-contact&utm_medium=email&utm_campaign=October-E-News
ORGANIZER;CN=CancerCare:MAILTO:
CATEGORIES:Informative Webinars and Events
END:VEVENT
END:VCALENDAR
